[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364334-105":59,"doc-detail-364334-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","global-dna-methylomes-reveal-oncogenic-associated-5-hydroxylmethylated-cytosine-5hmc-signatures-in-the-cell-free-dna-of-cancer-patients","Global DNA methylomes reveal oncogenic-associated 5-hydroxylmethylated cytosine (5hmC) signatures in the cell-free DNA of cancer patients","","Characterization of tumor epigenetic aberrations is essential for understanding tumorigenesis and for delivering diagnostic, prognostic, and predictive value in clinical settings. Among DNA methylation alterations, 5mC and 5hmC are closely linked to cancer biology, with 5hmC showing tissue-specific distribution and tumor-associated changes. This study performs unbiased, simultaneous base-resolution profiling of 5mC/5hmC across tumor tissues and matched cfDNA from bladder cancer and B-cell lymphoma cohorts to assess recapitulation and biomarker potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/global-dna-methylomes-reveal-oncogenic-associated-5-hydroxylmethylated-cytosine-5hmc-signatures-in-the-cell-free-dna-of-cancer-patients/364334/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/global-dna-methylomes-reveal-oncogenic-associated-5-hydroxylmethylated-cytosine-5hmc-signatures-in-the-cell-free-dna-of-cancer-patients/364334.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is 5hmC considered promising for cancer biomarker development?","Question",{"text":112,"@type":113},"5hmC has a tissue-specific distribution and its abundance changes in tumor DNA, enabling detection of tumor-related methylation alterations. The study evaluates whether these patterns can be captured non-invasively in cell-free DNA.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What did the study profile across cancer cohorts?",{"text":117,"@type":113},"The study performed unbiased, simultaneous detection of 5mC and 5hmC whole-genome DNA modifications at base resolution. It included two cancer cohorts (bladder cancer and B-Cell lymphoma) and analyzed corresponding normal tissues and plasma cfDNA.",{"name":119,"@type":110,"acceptedAnswer":120},"How did the researchers test whether cfDNA reflects tumor-associated 5hmC?",{"text":121,"@type":113},"They created a targeted capture strategy to examine 5hmC alterations in cfDNA with sufficient sensitivity and specificity. Results confirmed that cfDNA recapitulated patterns observed in tumor tissues.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},364334,1790610158,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","medRxiv preprint doi: [https://doi.org/10.1101/2025.01.09.25320283](https://doi.org/10.1101/2025.01.09.25320283); this version posted January 15, 2025. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.  \nIt is made available under a CC-BY-ND 4.0 International license .  \nGlobal DNA methylomes reveal oncogenic-associated 5-hydroxylmethylated cytosine (5hmC) signatures in the cell-free DNA of cancer patients  \nGabriel E. Rech 1, Alyssa C. Lau 1, Rachel L. Goldfeder 1, Rahul Maurya 1, Alexey V. Danilov2* and Chia-Lin Wei3* .  \n1. The Jackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA.  \n2. City of Hope National Medical Center, Duarte, CA, 91010, USA.  \n3. Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.  \n* CLW and AVD are [equally contributing senior authors. Corresponding author:](equally contributing senior authors. Corresponding author: weicl@uw.edu)[ ](equally contributing senior authors. Corresponding author: weicl@uw.edu)[weicl@uw.edu](equally contributing senior authors. Corresponding author: weicl@uw.edu)  \nAbstract  \nCharacterization of tumor epigenetic aberrations is integral to understanding the mechanisms of tumorigenesis and provide diagnostic, prognostic, and predictive information of high clinical relevance. Among the different tumor-associated epigenetic signatures, 5 methyl-cytosine (5mC) and 5-hydroxymethylcytosine (5hmC) are the two most well-characterized DNA methylation alterations linked to cancer pathogenesis. 5hmC has a tissue-specific distribution and its abundance is subjected to changes in tumor DNA, making it a promising biomarker. Detecting tumor-related DNA methylation alterations in tissues is highly invasive, while the analysis of the cell-free DNA (cfDNA) is poised to supplement, if not replace, surgical biopsies. Despite many studies attempted to identify new epigenetic targets for liquid biopsy assays, little is known about the regulatory roles of 5hmC, its impacts on the molecular phenotypes in tumors. Most importantly, whether the oncogenic-associated 5hmC signatures found in tumor tissues can be recapitulated in patients’cfDNA. In this study, we performed the unbiased and simultaneous detection of 5mC and 5hmCwhole-genome DNA modifications at base-resolution from two distinct cancer cohorts, from patients with bladder cancer or B-Cell lymphoma, their corresponding normal tissues, and cfDNAs from plasma. We analyzed tissue-specific methylation patters and searched for signatures in gene coding and regulatory regions linked to cancerous states. We then looked for methylation signatures in patients' cfDNA to determine if they were consistent with the tumor-specific patterns.  \nWe determined the functional significance of 5hmC in tissue specific transcription and uncovered hundreds of tumor-associated 5hmC signatures. These tumor-associated 5hmC changes, particularly in genes and enhancers, were functionally significant in tumorigenesis pathways and correlated with tumor specific gene expression. To investigate if cfDNA is a faithful surrogate for tumor-associated 5hmC, we devised a targeted capture strategy to examine the alterations of 5hmCin cfDNA from patients with bladder cancer and lymphoma with sufficient sensitivity and specificity and confirmed that they recapitulated the patterns we observed in tumor tissues. Our results provide analytic validation of 5hmC as a cancer-specific biomarker. The methods described here for systematic characterization of 5hmC at functional elements open new avenues to discover epigenetic markers for non-invasive diagnosis, monitoring, and stratifying cancer.  \n1  \nNOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.  \nmedRxiv preprint doi: [https://doi.org/10.1101/2025.01.09.25320283](https://doi.org/10.110","cbCaiqidKbsXp8Ce","https://ap.wps.com/l/cbCaiqidKbsXp8Ce","pdf",8223747,37,"English","# Abstract\n# Introduction","[{\"question\":\"Why is 5hmC considered promising for cancer biomarker development?\",\"answer\":\"5hmC has a tissue-specific distribution and its abundance changes in tumor DNA, enabling detection of tumor-related methylation alterations. The study evaluates whether these patterns can be captured non-invasively in cell-free DNA.\"},{\"question\":\"What did the study profile across cancer cohorts?\",\"answer\":\"The study performed unbiased, simultaneous detection of 5mC and 5hmC whole-genome DNA modifications at base resolution. It included two cancer cohorts (bladder cancer and B-Cell lymphoma) and analyzed corresponding normal tissues and plasma cfDNA.\"},{\"question\":\"How did the researchers test whether cfDNA reflects tumor-associated 5hmC?\",\"answer\":\"They created a targeted capture strategy to examine 5hmC alterations in cfDNA with sufficient sensitivity and specificity. Results confirmed that cfDNA recapitulated patterns observed in tumor tissues.\"}]","Global DNA methylomes reveal oncogenic-associated 5-hydroxylmethylated cytosine (5hmC) signatures in the cell-free DNA of cancer patients | PDF",1790157050,93,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d550c3e96dea30e3d2694329b35ad748.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/35082bb91fef8268ed5b9f8f9b47bd54.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/775f4c3fea620f31bef5fe92be87f240.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7686454b9afa69a79214100e45549f19.webp",980,1268]